Ignite Creation Date:
2025-12-24 @ 5:48 PM
Ignite Modification Date:
2026-01-22 @ 12:01 PM
Study NCT ID:
NCT05637268
Status:
UNKNOWN
Last Update Posted:
2022-12-05
First Post:
2022-11-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell Carcinoma
Sponsor:
Organization: